Faculty Information - IZUKA Yuki

■ Published papers

1.	Original article	Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes. 2024/02/27
2.	Original article	Very Early Increased Platelet Count within a Week after Initiation of High-Dose Dexamethasone Treatment Is Associated with Long-Term Response in Newly Diagnosed Immune Thrombocytopenia Patients. 2022/02
3.	Case report	Successful Rituximab Treatment in Thrombotic Thrombocytopenic Purpura Patients Complicated by Other Autoimmune Disorders: Two Case Reports. 2021/09
4.	Original article	Phase I study of cellular therapy using ex vivo expanded NK cell from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients. 2020/04
5.	Original article	Herpes zoster after autologous haematopoietic stem cell transplantation without antiviral prophylaxis. 2019/09
6.	Case report	A Case of Primary Bilateral Adrenal Marginal Zone Lymphoma with Cavernous Sinus and Lung Involvements 2013/03/31
7.	Original article	Usefulness of the revised international prognostic index for diffuse large B-cell lymphoma patients treated with rituximab-based chemotherapy 2013/03
Display 5 items
Display all(7)

■ Academic conference presentation

1.	Clinical course of immune thrombocytopenia after COVID-19 vaccination 2022/10/16
2.	Clinical features of MTX-associated lymphoproliferative disorders in rheumatoid arthritis patients 2022/10/16
3.	4 cases of COVID-19 infection in patients with hematological diseases 2021/09/23
4.	A case of primary mediastinal large B-cell lymphoma with pancreas involvement 2021/09/23
5.	Retrospective analysis of chronic myelomonocytic leukemia 2021/09/23
6.	Safety and efficacy of obinutuzumab-based chemoimmunotherapy for follicular lymphoma patients 2021/09/23
7.	Successful treatment with daratumumab in multiple myeloma patient with severe renal impairment 2021/09/23
8.	Clinical Features of Post-Transplant Lymphoproliferative Disease Are Different between Kidney-Transplant Recipients from a Cadaveric Donor and Those from a Living Donor 2019/12/08
9.	Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/ II Clinical Trial in Progress 2019/12/08
10.	Successful combined Treatment of blinatumomab and donor lymphocyte infusion after haploidentical hematopoietic cell transplantation in a relapsed Ph+ALL patient with BCR/ABL1 compound mutation 2019/08/30
11.	Non-Hodgkin lymphoma in patients with myeloproliferative neoplasms 2019/06/15
12.	Herpes zoster after autologous hematopoietic stem cell transplantation without antiviral prophylaxis 2018/03/20
13.	Long term efficacy of high dose dexamethasone for immune thrombocytopenia 2017/10/22
14.	Clinical characteristics of CNS relapse in patients with diffuse large B-cell lymphoma 2017/10/20
15.	HSV and VZV disease during the first year after autologous hematopoietic stem cell transplantation 2017/10/20
16.	Retrospective analyse of methotrexate associated lymphoma 2017/10/20
17.	Autologous peripheral blood stem cell harvesting/ transplantation using modified Dexa-BEAM/BEAM regimens for the patients with high-risk lymphomas: a single center retrospective study. 2016/10/29
18.	Seven cases of non-Hodgkin B-cell lymphoma with heart involvement at diagnosis 2016/10/13
19.	RELAL-88 exhibited high remission rates in refractory or relapsed adult precursor lymphoid neoplasms 2014/10/31
20.	Thrombotic thrombocytopenic purpura diagnosed after a twenty-year history of thrombocytopenia 2013/10/12
21.	A case of acute myeloid leukemia with t(11;19) (q23;p13.1) accompanied by severe DIC 2013/10/11
Display 5 items
Display all(21)

■ Education

1.

2004/04～2010/03

Faculty of Medicine, Tokyo Women's Medical University, Graduated